New protein complex may explain why patients develop resistance to novel anti-cancer

[News]

A team of researchers at the University of Cambridge has identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication.

More... (https://www.news-medical.net/news/20180725/New-protein-complex-may-explain-why-patients-develop-resistance-to-novel-anti-cancer-drugs.aspx)